Multicentre, Double-blind, Randomized, Placebo-controlled Trial of Clinical Efficacy of Burdock Root Extract in Patients With Asymptomatic Hyperuricaemia
Multicentre, double-blind, randomized, placebo-controlled trial of the clinical efficacy of burdock root extract in patients with asymptomatic hyperuricemia, with the primary objective to assess the efficacy of the use of burdock root extract in patients with asymptomatic hyperuricaemia versus placebo
• Hyperuricaemia confirmed by a laboratory, uric acid level from 360 to 540 μmol/L in women and from 420 to 540 μmol/L in men;
‣ Age from 35 to 65 years at the baseline;
⁃ Patients examined by an experienced specialist not revealing any clinical evidences of gout or other somatic consequences of hyperuricaemia;
⁃ Not taking any other nutritional additives;
⁃ Women of reproductive age having negative pregnancy test at the baseline and at the end of the trial;
⁃ Not taking any diuretics, or their administration based on a regimen usual for a patient, without changes;
⁃ Not taking part in any other clinical trials;
⁃ Consent and voluntarily signed informed consent form for participation in the clinical trial.